$ABIO Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ARCA biopharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ARCA biopharma, Inc.. Get notifications about new insider transactions in ARCA biopharma, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 09 2006 | ABIO | ARCA biopharma, In ... | SOBEL BURTON E | Director | Sell | S | 15.59 | 1,100 | 17,146 | 60,000 | 61.1 K to 60 K (-1.80 %) |
Jun 09 2006 | ABIO | ARCA biopharma, In ... | SOBEL BURTON E | Director | Sell | S | 15.58 | 3,900 | 60,770 | 61,100 | 65 K to 61.1 K (-6.00 %) |
Jun 09 2006 | ABIO | ARCA biopharma, In ... | SOBEL BURTON E | Director | Option Exercise | A | 14.66 | 15,000 | 219,900 | 15,000 | |
May 25 2006 | ABIO | ARCA biopharma, In ... | GAVIN JAMES R III | Director | Option Exercise | A | 14.66 | 25,000 | 366,500 | 25,000 | |
Jun 08 2006 | ABIO | ARCA biopharma, In ... | PERRY MARK L | Director | Option Exercise | A | 14.66 | 15,000 | 219,900 | 15,000 | |
May 25 2006 | ABIO | ARCA biopharma, In ... | ZUBROW BARRY L | Director | Option Exercise | A | 14.66 | 20,000 | 293,200 | 20,000 | |
May 25 2006 | ABIO | ARCA biopharma, In ... | Popovits Kimberly J | Director | Option Exercise | A | 14.66 | 15,000 | 219,900 | 15,000 | |
May 25 2006 | ABIO | ARCA biopharma, In ... | PENDERGAST MARY K | Director | Option Exercise | A | 14.66 | 15,000 | 219,900 | 15,000 | |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Option Exercise | A | 9.16 | 190 | 1,740 | 190 | |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Option Exercise | A | 9.16 | 124,810 | 1,143,260 | 124,810 | |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Buy | I | 6.30 | 167 | 1,052 | 167 | 0 to 167 |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Buy | I | 6.60 | 159 | 1,049 | 159 | 0 to 159 |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | LEVY MICHAEL D | Sr. VP Research & D ... | Option Exercise | A | 9.16 | 10,915 | 99,981 | 10,915 | |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | LEVY MICHAEL D | Sr. VP Research & D ... | Option Exercise | A | 9.16 | 189,085 | 1,732,019 | 189,085 | |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | LEVY MICHAEL D | Sr. VP Research & D ... | Buy | I | 6.30 | 1,486 | 9,362 | 1,486 | 0 to 1.5 K |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr VP CFO & General ... | Option Exercise | A | 9.16 | 190 | 1,740 | 190 | |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr VP CFO & General ... | Option Exercise | A | 9.16 | 149,810 | 1,372,260 | 149,810 | |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | LOVE TED W | President and C.E.O ... | Option Exercise | A | 9.16 | 500,000 | 4,580,000 | 500,000 | |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | LOVE TED W | President and C.E.O ... | Buy | I | 6.30 | 2,378 | 14,981 | 2,378 | 0 to 2.4 K |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | LOVE TED W | President and C.E.O ... | Buy | I | 7.57 | 361 | 2,733 | 361 | 0 to 361 |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | LOVE TED W | President and C.E.O ... | Buy | I | 7.40 | 999 | 7,393 | 999 | 0 to 999 |
Aug 03 2005 | ABIO | ARCA biopharma, In ... | LOVE TED W | President and C.E.O ... | Buy | I | 10.45 | 703 | 7,346 | 703 | 0 to 703 |
Jul 19 2005 | ABIO | ARCA biopharma, In ... | Popovits Kimberly J | Director | Option Exercise | A | 8.62 | 25,000 | 215,500 | 25,000 | |
May 26 2005 | ABIO | ARCA biopharma, In ... | PENDERGAST MARY K | Director | Option Exercise | A | 6.73 | 15,000 | 100,950 | 15,000 | |
May 26 2005 | ABIO | ARCA biopharma, In ... | PERRY MARK L | Director | Option Exercise | A | 6.73 | 15,000 | 100,950 | 15,000 | |
May 26 2005 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 6.73 | 25,000 | 168,250 | 25,000 | |
May 26 2005 | ABIO | ARCA biopharma, In ... | SOBEL BURTON E | Director | Option Exercise | A | 6.73 | 15,000 | 100,950 | 15,000 | |
May 26 2005 | ABIO | ARCA biopharma, In ... | ZUBROW BARRY L | Director | Option Exercise | A | 6.73 | 20,000 | 134,600 | 20,000 | |
May 12 2005 | ABIO | ARCA biopharma, In ... | LEVY MICHAEL D | Sr. VP Research & D ... | Buy | P | 6.31 | 9,000 | 56,790 | 9,000 | 0 to 9 K |
Mar 25 2005 | ABIO | ARCA biopharma, In ... | PENDERGAST MARY K | Director | Option Exercise | A | 6.50 | 25,000 | 162,500 | 25,000 | |
Mar 25 2005 | ABIO | ARCA biopharma, In ... | PERRY MARK L | Director | Option Exercise | A | 6.50 | 25,000 | 162,500 | 25,000 | |
Mar 25 2005 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 6.50 | 50,000 | 325,000 | 50,000 | |
Mar 25 2005 | ABIO | ARCA biopharma, In ... | ZUBROW BARRY L | Director | Option Exercise | A | 6.50 | 35,000 | 227,500 | 35,000 | |
Mar 25 2005 | ABIO | ARCA biopharma, In ... | SOBEL BURTON E | Director | Option Exercise | A | 6.50 | 25,000 | 162,500 | 25,000 | |
Mar 01 2005 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 7.72 | 1,000 | 7,720 | 1,000 | |
Feb 01 2005 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 7.98 | 1,000 | 7,980 | 1,000 | |
Feb 24 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Buy | P | 7.51 | 1,500 | 11,265 | 1,879 | 379 to 1.9 K (+395.78 %) |
Feb 24 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Buy | I | 7.69 | 136 | 1,046 | 379 | 243 to 379 (+55.97 %) |
Jan 12 2005 | ABIO | ARCA biopharma, In ... | LOVE TED W | President and C.E.O ... | Option Exercise | A | 9.83 | 15,178 | 149,200 | 15,178 | |
Jan 12 2005 | ABIO | ARCA biopharma, In ... | LOVE TED W | President and C.E.O ... | Option Exercise | A | 9.83 | 284,822 | 2,799,800 | 284,822 | |
Jan 11 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Option Exercise | A | 9.83 | 10,833 | 106,488 | 10,833 | |
Jan 11 2005 | ABIO | ARCA biopharma, In ... | Titus Gary | VP Finance, Chief A ... | Option Exercise | A | 9.83 | 39,167 | 385,012 | 39,167 | |
Jan 11 2005 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr VP CFO & General ... | Option Exercise | A | 9.83 | 10,833 | 106,488 | 10,833 | |
Jan 11 2005 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Sr VP CFO & General ... | Option Exercise | A | 9.83 | 39,167 | 385,012 | 39,167 | |
Dec 30 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 10.13 | 1,000 | 10,130 | 1,000 | |
Dec 30 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Gift | G | 10.14 | 44,000 | 445,940 | 903,788 | 947.8 K to 903.8 K (-4.64 %) |
Dec 01 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 9.90 | 1,000 | 9,900 | 1,000 | |
Nov 24 2004 | ABIO | ARCA biopharma, In ... | LEVY MICHAEL D | Sr. VP Research & D ... | Option Exercise | A | 9.83 | 40,688 | 399,963 | 40,688 | |
Nov 24 2004 | ABIO | ARCA biopharma, In ... | LEVY MICHAEL D | Sr. VP Research & D ... | Option Exercise | A | 9.83 | 134,312 | 1,320,287 | 134 | |
Nov 02 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 9.28 | 1,000 | 9,280 | 1,000 | |
Nov 01 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 9.85 | 1,000 | 9,850 | 1,000 | |
Sep 16 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 9.67 | 400,000 | 3,868,000 | 400,000 | |
Sep 15 2004 | ABIO | ARCA biopharma, In ... | Titus Gary | V.P. and Chief Acct ... | Option Exercise | A | 9.67 | 19,932 | 192,742 | 19,932 | |
Sep 15 2004 | ABIO | ARCA biopharma, In ... | Titus Gary | V.P. and Chief Acct ... | Option Exercise | A | 9.67 | 20,068 | 194,058 | 20,068 | |
Sep 02 2004 | ABIO | ARCA biopharma, In ... | CREDIT SUISSE FIRST BOSTON/ | Option Exercise | C | 4.98 | 698 | 3,476 | 0 | ||
Sep 02 2004 | ABIO | ARCA biopharma, In ... | CREDIT SUISSE FIRST BOSTON/ | Option Exercise | C | 4.98 | 12,562 | 62,559 | 0 | ||
Sep 02 2004 | ABIO | ARCA biopharma, In ... | CREDIT SUISSE FIRST BOSTON/ | Option Exercise | C | 4.98 | 209,364 | 1,042,633 | 0 | ||
Sep 02 2004 | ABIO | ARCA biopharma, In ... | CREDIT SUISSE FIRST BOSTON/ | Option Exercise | C | 4.98 | 18,218 | 90,726 | 0 | ||
Sep 02 2004 | ABIO | ARCA biopharma, In ... | CREDIT SUISSE FIRST BOSTON/ | Buy | C | 4.98 | 698 | 3,476 | 7,230 | 6.5 K to 7.2 K (+10.69 %) | |
Sep 02 2004 | ABIO | ARCA biopharma, In ... | CREDIT SUISSE FIRST BOSTON/ | Buy | C | 4.98 | 12,562 | 62,559 | 130,088 | 117.5 K to 130.1 K (+10.69 %) | |
Sep 02 2004 | ABIO | ARCA biopharma, In ... | CREDIT SUISSE FIRST BOSTON/ | Buy | C | 4.98 | 209,364 | 1,042,633 | 1,215,554 | 1 M to 1.2 M (+20.81 %) | |
Sep 02 2004 | ABIO | ARCA biopharma, In ... | CREDIT SUISSE FIRST BOSTON/ | Buy | C | 4.98 | 18,218 | 90,726 | 188,667 | 170.4 K to 188.7 K (+10.69 %) | |
Sep 15 2004 | ABIO | ARCA biopharma, In ... | SOBEL BURTON E | Director | Option Exercise | A | 9.67 | 10,000 | 96,700 | 10,000 | |
Jul 30 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 7.97 | 1,000 | 7,970 | 1,000 | |
Sep 01 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 8.60 | 1,000 | 8,600 | 1,000 | |
Jul 13 2004 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Senior VP and Gener ... | Option Exercise | A | 8.41 | 47,560 | 399,980 | 47,560 | |
Jul 13 2004 | ABIO | ARCA biopharma, In ... | BENDEKGEY E LEE | Senior VP and Gener ... | Option Exercise | A | 8.41 | 77,440 | 651,270 | 77,440 | |
Jun 30 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 9.77 | 1,000 | 9,770 | 1,000 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | GARCIA PETER S | Senior V.P. and C.F ... | Option Exercise | A | 10.18 | 12,644 | 128,716 | 12,644 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | GARCIA PETER S | Senior V.P. and C.F ... | Option Exercise | A | 10.18 | 37,356 | 380,284 | 37,356 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | GARCIA PETER S | Senior V.P. and C.F ... | Option Exercise | A | 10.18 | 110,000 | 1,119,800 | 110,000 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 8.77 | 1,000 | 8,770 | 1,000 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | FITZPATRICK LINDA A | Senior V.P. of Huma ... | Option Exercise | A | 10.18 | 12,644 | 128,716 | 12,644 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | FITZPATRICK LINDA A | Senior V.P. of Huma ... | Option Exercise | A | 10.18 | 37,356 | 380,284 | 37,356 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | FITZPATRICK LINDA A | Senior V.P. of Huma ... | Option Exercise | A | 10.18 | 75,000 | 763,500 | 75,000 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | LOVE TED W | President and C.E.O ... | Option Exercise | A | 10.18 | 11,581 | 117,895 | 11,581 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | LOVE TED W | President and C.E.O ... | Option Exercise | A | 10.18 | 138,419 | 1,409,105 | 138,419 | |
Jun 01 2004 | ABIO | ARCA biopharma, In ... | LOVE TED W | President and C.E.O ... | Option Exercise | A | 10.18 | 350,000 | 3,563,000 | 350,000 | |
May 10 2004 | ABIO | ARCA biopharma, In ... | ZUBROW BARRY L | Director | Option Exercise | A | 11.11 | 7,500 | 83,325 | 7,500 | |
May 10 2004 | ABIO | ARCA biopharma, In ... | PERRY MARK L | Director | Option Exercise | A | 11.11 | 7,500 | 83,325 | 7,500 | |
May 10 2004 | ABIO | ARCA biopharma, In ... | PENDERGAST MARY K | Director | Option Exercise | A | 11.11 | 7,500 | 83,325 | 7,500 | |
Apr 30 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 11.06 | 1,000 | 11,060 | 1,000 | |
May 10 2004 | ABIO | ARCA biopharma, In ... | CHAMBON PHILIPPE | Director | Option Exercise | A | 11.11 | 7,500 | 83,325 | 7,500 | |
Apr 01 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 12.57 | 1,000 | 12,570 | 1,000 | |
Mar 01 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 12.12 | 1,000 | 12,120 | 1,000 | |
Feb 23 2004 | ABIO | ARCA biopharma, In ... | ZUBROW BARRY L | Director | Buy | P | 4.65 | 50,000 | 232,500 | 50,000 | 0 to 50 K |
Feb 05 2004 | ABIO | ARCA biopharma, In ... | ZUBROW BARRY L | Director | Option Exercise | A | 5.30 | 10,000 | 53,000 | 10,000 | |
Jan 05 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 3.50 | 3,000 | 10,500 | 3,000 | |
Feb 02 2004 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 4.43 | 3,000 | 13,290 | 3,000 | |
Dec 22 2003 | ABIO | ARCA biopharma, In ... | PENDERGAST MARY K | Director | Grant | A | 3.17 | 1,000 | 3,170 | 2,000 | 1,000 to 2 K (+100.00 %) |
Dec 22 2003 | ABIO | ARCA biopharma, In ... | PENDERGAST MARY K | Director | Grant | A | 3.16 | 1,000 | 3,160 | 1,000 | 0 to 1,000 |
Dec 02 2003 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 3.83 | 3,000 | 11,490 | 3,000 | |
Nov 04 2003 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 3.40 | 3,000 | 10,200 | 3,000 | |
Oct 07 2003 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 2.72 | 3,000 | 8,160 | 3,000 | |
Sep 03 2003 | ABIO | ARCA biopharma, In ... | RATHMANN GEORGE B | Director | Option Exercise | A | 2.03 | 3,000 | 6,090 | 3,000 |